PubMed Health⌕ Search

PubMed · 2643839

[Risk assessment in hematologic diseases].

Abstract

The insurance of one's life and one's capacity to work is only exceptionally possible for patients suffering from haematological diseases. Most of these diseases are still fatal after a predictable and thus a short period, in spite of certain therapeutical results. Exceptions such as the healing of, for instance, a lymphatic leucocythaemia are mentioned. It will be dealt with the approximate frequency of the disease, its characteristics and its prognosis.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H Linker. 1989-01-01. [Risk assessment in hematologic diseases].. https://pubmed.ncbi.nlm.nih.gov/2643839/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Occurrence of the yeast and filamentous fungi in haematological patients during 2002 to August 2005].

BACKGROUND: The number of diseases caused by yeast and fungi has been increasing recently. The primary disease is caused by dermatophytes and Cryptococcus neoformans. Other types of yeast and fungi can cause secondary infections of patients with predisposition factors. Among the mycotic diseases diagnosed in our laboratory can be included candidosis, cryptococcosis, aspergillosis and mucormycosis. METHODS AND RESULTS: In haematological patients Candida albicans, Candida glabrata, Candida krusei, Candida tropicalis and Saccharomyces cerevisiae are the most frequently diagnosed. CONCLUSIONS: Together with the increased number of examined samples, the rising number of strains resistant to azole antimycotics can be observed.

Hematologic Diseases↗